FCRL3 and rheumatoid arthritis: Genetic variants of FCRL3, especially the −169C/T polymorphism (rs7528684) within the promoter region, can influence protein expression and thus alter susceptibility to autoimmune diseases, including RA, systemic lupus erythematosus, and autoimmune thyroid disorders [25].